ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633781 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633781; 2) Community: the network communities that were significantly associated with the response to NSC 633781; 3) Molecule: the relationships between components within communities and NSC 633781; 4) MDR: the compounds that were significantly associated with the NSC 633781.

NSC Compound Enrichment Correlation
NSC 735540 5-fluoro-N-(2-methyl-3-oxo-8-phenyl-1-thia-4-azaspiro[4.5]de c-4-yl)-3-phenyl-1H-indole-2-carboxamide 0.00707875925191925 0.2001094
NSC 737613 Null 0.00707875925191925 -0.1376431
NSC 652924 Null 0.00744479268267742 0.12012058
NSC 760978 Null 0.00744479268267742 -0.10500525
NSC 762934 Null 0.00744479268267742 0.35030696
NSC 102817 Germacra-1(10),11(13)-diene-12,14-dioic acid, 4,5.alpha.-epoxy-2.beta.,6.alpha.,8.alpha.-trihydroxy-, 12,6:14,2-dilactone, 3-methylcrotonate (8CI) 0.00744479268267747 0.00085088769
NSC 294734 7-Oxabicyclo[4.1.0]hept-3-ene-2,5-dione, 3-hydroxy-4-methyl-, (1R-cis)- 0.00744479268267747 0.010348968
NSC 662123 Null 0.00845932736945076 0.18474967
NSC 681639 Camptothecin Derivative 0.00845932736945076 0.26816479
NSC 683662 2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[2-(dimethylamino)-1-oxoethoxy]-19-[(2-propenyl)amino]-, stereo 0.00845932736945076 -0.031231994
Total:78  Current:16    [First] [Prev] [Next] [Last]